4//SEC Filing
KENNEY CHRISTOPHER JOHN 4
Accession 0001209191-21-053304
CIK 0001582313other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 4:12 PM ET
Size
5.4 KB
Accession
0001209191-21-053304
Insider Transaction Report
Form 4
KENNEY CHRISTOPHER JOHN
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-08-23+150,000→ 150,000 totalExercise: $16.64Exp: 2031-08-22→ Common Shares (150,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on the one year anniversary of the grant date, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001880129
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 4:12 PM ET
- Size
- 5.4 KB